Read + Share
Amedeo Smart
Independent Medical Education
Mahase E. Tirzepatide: NICE recommends another GLP-1 agonist for type 2 diabetes. BMJ 2023;382:2074.PMID: 37696547
Email
LinkedIn
Facebook
Twitter
Privacy Policy